project id: TCGA-ACC; case submitter id: TCGA-OR-A5JO; source center: 23; state: released; a260 a280 ratio: 1.84; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.26; rna integrity number: 7.1; age at index: 26; days to birth: -9547; ethnicity: not reported; gender: female; race: white; vital status: Alive; year of birth: 1979; age at diagnosis: 9547; ajcc clinical m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage I; ajcc pathologic t: T1; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1194.0; icd 10 code: C74.0; last known disease status: not reported; morphology: 8370/3; primary diagnosis: Adrenal cortical carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cortex of adrenal gland; synchronous malignancy: No; tissue or organ of origin: Cortex of adrenal gland; tumor grade: Not Reported; year of diagnosis: 2005; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 2773; initial weight: 20.0; sample id: 2d1788c4-196f-48c3-b0ec-e3f8de351607; sample submitter id: TCGA-OR-A5JO-01A; portion id: aac42081-3da4-4adc-9d6e-95cbe0a734ad; portion submitter id: TCGA-OR-A5JO-01A-11; slide id: be82fadf-3717-418e-aaf4-16003f52e72f; slide submitter id: TCGA-OR-A5JO-01A-01-TS1; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 5.0; percent tumor cells: 95.0; percent tumor nuclei: 90.0; section location: TOP;